"Welcome to National Allergy & ENT where we pride ourselves on providing compassionate and efficient care for busy families and professionals. Our staff will make every effort to make you feel comfortable, maximize your time with the doctor, answer all of your questions, and minimize waiting time. Our board certified physicians are dedicated to providing the most up-to-date treatment for adults and children with allergy, ENT, facial plastic, asthma, or immunologic disorders. We offer world-class expertise and the highest standard in diagnostic testing and treatment for allergy, ENT, asthma, and immunology."

During the past decade, National Allergy and Asthma Research, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Allergy and Asthma Research, LLC" #1 sponsor was "Meda Pharmaceuticals" with 9 trials, followed by "Aimmune Therapeutics, Inc." with 4 trials sponsored, "LEO Pharma" with 2 trials sponsored, "Magna Pharmaceuticals, Inc." with 2 trials sponsored and "Regeneron Pharmaceuticals" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Allergy and Asthma Research, LLC" #1 collaborator was "Sanofi" with 2 trials as a collaborator and "Novella Clinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Allergy and Asthma Research, LLC" are "Peanut Allergy" (6 trials), "Seasonal Allergic Rhinitis" (6 trials), "Atopic Dermatitis" (3 trials), "Allergic Rhinitis" (2 trials) and "Asthma" (2 trials). Many other conditions were trialed in "National Allergy and Asthma Research, LLC" in a lesser frequency.

Most popular intervention types in "National Allergy and Asthma Research, LLC" are "Drug" (23 trials), "Biological" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "AR101" (3 trials), "fluticasone propionate" (3 trials), "0.15% azelastine hydrochloride" (2 trials) and "azelastine Hcl" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Allergy and Asthma Research, LLC" are 30 trials for "All" genders.

Currently, there are NaN active trials in "National Allergy and Asthma Research, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in National Allergy and Asthma Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Allergy and Asthma Research, LLC, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".